Anna Protopapas

Ms. Anna Protopapas is a Chief Executive Officer & Director at Flare Therapeutics, Inc. and an Independent Chairman at Nuvalent, Inc. She is on the Board of Directors at Flare Therapeutics, Inc. Ms. Protopapas was previously employed as an Independent Director by Dicerna Pharmaceuticals, Inc., an Independent Director by ARIAD Pharmaceuticals, Inc., an Executive VP-Global Business Development by Takeda Pharmaceutical Co., Ltd., a Head-Global Business Development by Takeda Pharmaceuticals International, Inc., and a President & Chief Executive Officer by Takeda Oncology Co. She also served on the board at Bioverativ, Inc., Mersana Therapeutics, Inc. and Ensemble Therapeutics Corp.
She received her undergraduate degree from Princeton University, a graduate degree from Massachusetts Institute of Technology and an MBA from Stanford Graduate School of Business.